Sign in
Taking people in United StatesNo phase

Heart ultrasound to see how the Impella pump affects both heart chambers

Uses heart ultrasound to study Impella 5.5 in adults with end-stage heart failure.

Key facts

Who runs it
University of Rochester
Where
Rochester, United StatesSee the site
Trial code
Registry title
Echocardiographic Assessment of the Effect of Impella on Biventricular Function
Status
Recruiting
People taking part
24 people, planned
Started
11 Jul 2026
Expected to end
1 Jul 2027
Type of study
Observational
Treatments tested
  • Echocardiographic Assessment
Record updated
9 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with end-stage heart failure who need an Impella 5.5 heart pump. Heart scans will track how the pump affects both sides of the heart.

Age
Over 18 years old
Sex
All sexes can join
Disease stage
End-stage heart failure that needs temporary mechanical circulatory support

Main reasons for not taking part

  • Cannot give consent for themselves, including not understanding the research
  • Higher-than-normal risk of problems from the heart ultrasound through the throat, such as swallowing problems (dysphagia) or esophagus disease

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Adult patients over 18 years old
  • Require Impella 5.5 implantation

Who cannot take part

  • Patients' inability to provide consent for themselves (including that patients' lack of understanding the research)
  • Any patients who are deemed at higher-than-normal risk for complications secondary to echocardiography, such as dysphagia or esophageal pathology

Where in United States

  • University of Rochester Medical CenterRochester, United StatesContact: YOSHIHISA MORITATaking people

About the trial

What the trial wants to find out

The objective of this prospective observational study is to evaluate the effects of Impella 5.5 on biventricular function in adult patients with end-stage heart failure requiring temporary mechanical circulatory support. The study will assess changes in left and right ventricular global longitudinal strain and myocardial work, as well as additional echocardiographic and hemodynamic parameters. Measurements will be obtained at baseline prior to Impella implantation, immediately after device initiation, and during postoperative follow-up up to Day 14. This study involves collection of echocardiographic imaging and clinical data, including additional imaging performed for research purposes.

The group in the trial

  • End-stage heart failure patients receiving Impella 5.5

    Adult patients with end-stage heart failure requiring Impella 5.5 for temporary mechanical circulatory support.

    Treatment: Echocardiographic Assessment

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Echocardiographic Assessment of the Effect of Impella on Biventricular Function
Plain-language title
Heart ultrasound to see how the Impella pump affects both heart chambersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
9 September 2026